Towards a cleaner environment
Virotec Aqua Solve LLC
Homepage
News
Contact Us
 

CORPORATE INFORMATION

Virotec is leading the way in meeting the demand for new and practical solutions to tough environmental problems. The Company has developed breakthrough, economical technologies to treat highly contaminated waste rock, soils, waste water and sludge – enabling companies to meet regulatory standards, reduce future liabilities and help preserve our environment.

Bauxsol™ Technology is the platform technology upon which the company has developed its solutions and product lines. The technology’s main applications arise from its ability to treat contamination caused by heavy metals and acidity.

Virotec International plc is incorporated and registered in England and Wales under the Companies Act 1985 with registered number 5796515.

Virotec’s countries of operation are the United Kingdom, the United States of America, Australia and Italy.

 

BOARD OF DIRECTORS:

Name, position

Qualifications, experience, special responsibilities and other directorships

Mr Brian Sheeran

Mr Sheeran is a member of the Australian Institute of Company Directors. He started his career in mechanical engineering and gained further experience as a successful owner/operator in the marine and road transport industries. He has been a director of various companies, covering mining, timber, farming ventures, earthmoving and haulage. He is a highly respected and successful businessman. Mr. Sheeran has been a Director since 1997, and was appointed Chairman in 1999. Mr Sheeran was appointed as a director of HydroDec Group plc, in December 2004 and The Greenhouse Fund Limited in August 2006.

Chairman
 
 
 
 
 

Mr Bruno Bamonte

Mr Bamonte is a Chartered Accountant and a member of the Australian Institute of Company Directors. He has consulted to a number of public companies on a range of areas including preparation of prospectuses, assistance to gain admission to the official list of the Australian Stock Exchange, assistance to seek requotation of shares for suspended companies, corporate governance, and other financial areas. Mr Bamonte has been a Director since 1997. He was appointed as a director of HydroDec Group plc in December 2004.

Chief Financial Officer
 
 
 

Mr John Glynn

Mr Glynn is a practising lawyer with his own firm in Tamworth, NSW. He was admitted as a Solicitor in 1980. He practised in partnership in regional NSW for 10 years before establishing his own practice, as well as being admitted to practice in Queensland. He has appeared in the Land and Environment Court and has a particular interest in environmental, company and aviation law. Mr Glynn was appointed as a Director in March 2000 and is chairman of the audit committee and remuneration committee.

 

Non-Executive Director
 
 

Dr David McConchie

Dr McConchie is a Professor of Engineering and Environmental Geochemistry in the Centre for Coastal Management at Southern Cross University and a co-founder of the Centre for Research on Acid Sulphate Soils. He gained his MSc in geology (with distinction) in 1978 from the University of Canterbury, New Zealand and was awarded a PhD in 1985 by the University of Western Australia. He has published over 60 research papers and 5 books. Dr David McConchie was appointed as a Director in July 2000.

 

Executive Director
 
 
 
 
Mr Justin Seager

Mr Seager has worked in the financial services sector in London as a fund manager for the past 20 years. Initially he worked for Kleinwort Benson, in the investment management division, becoming a director and managing a range of institutional and retail portfolios. Kleinworts was acquired by Dresdner Bank during this period. Mr Seager left Dresdner Bank in 2000 to join Jupiter, becoming a director of Jupiter Asset Management and of Jupiter Unit Trust Managers. He left Jupiter in April 2007 to pursue other business interests. Mr Seager is a member of Virotec’s audit and the remuneration committees.

 

Non-Executive Director
 
 
 
 

COMMITTEES OF THE BOARD:

Audit committee

The audit committee comprises the two non non-executive directors under the chairmanship of Mr John Glynn. It overviews the monitoring of the Group’s internal controls, accounting policies and financial reporting and provides a forum through which the external auditors report. It also reviews the scope and results of the external audit and the independence and objectivity of the auditors and makes recommendations to the Board on issues surrounding their remuneration, appointment, resignation or removal.

 

Remuneration committee

The remuneration committee comprises the two non-executive directors under the chairmanship of Mr John Glynn. It reviews, inter alia, the performance of the executive directors and sets the scale and structure of their remuneration and the basis of their service agreements with due regard to the interests of the shareholders.

 

SHARE CAPITAL:

As at 30 June 2007, Virotec has 264,168,231 ordinary shares on issue and admitted to trading on AIM. It does not hold any shares as treasury shares, nor are there any restrictions on transfers of its ordinary shares. As of 30 June 2007, 7.2% of the Company's ordinary shares are not in public hands.

As at 30 June 2007, Virotec has been notified of the following significant shareholdings:

 

Aviva plc
38,008,117
ordinary shares
14.39%
JM Finn & co Ltd
15,280,000
ordinary shares
5.78 %
Fidelity International Ltd
14,423,307
ordinary shares
5.46%
FMR Corp.
3,411,132
ordinary shares
1.29%
PIHL Equity LLP
10,583,333
ordinary shares
4.01%
Mr Nigel Wray
15,962,209
ordinary shares
6.04%

 

ADVISORS:

 

Nominated Advisor:

Arden Patners plc

Nicholas House

3 Laurence Pountney Hill

London EC4R 0EU

   
Broker:

Numis Securities Ltd

The London Stock Exchange Building

No. 10 Paternoster Square

London EC4M 7LT

 

Legal Advisers:

Cobbetts LLP

Ship Canal House

King Street

Manchester  M2 4WB

 

McCullough Robertson

Level 11

Central Plaza Two

66 Eagle Street

Brisbane, Queensland  4000

Australia

 

Registrars:

Computershare Investor Services PLC

The Registrar

PO Box 82, The Pavilions

Bridgewater Road

Bristol  BS99 7NH

 

Auditors:

KPMG Audit Plc

8 Salisbury Square

London  EC4Y 8BB

 

COMPANY POLICIES:

Virotec International plc has the following policies in place:

Environmental Policy

Occupational Health and Safety Policy

Risk Management Policy

 

AIM RULE 26:

This website contains management and financial information and has been prepared to comply with the requirements of Rule 26 of the AIM Rules for Companies.

The website was last updated on 22 January 2008..

Virotec


Corporate InformationShareholder EnquiriesAIM ListingAnnual Reports Articles of AssociationAdmission Document